Arkolith/Insider Trading/BIXT/Form 4

Hoberman Alan M

DirectorBIOXYTRAN, INC (BIXT) · full profile →Form 4 · filed Jan 18, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 29, 2021Grant(A)80K—$0444K
Apr 2, 2021Grant(A)30K$0.17$5K364K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001539497-22-000075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML